Moody's Corporation
MCO
$506.28
-0.38%
Moody's Corporation operates a two-segment financial information franchise: Moody's Investors Service (MIS), one of the two dominant global credit rating agencies for corporate, structured finance, financial institution, and public finance debt, and Moody's Analytics, which sells decision solutions, research, data, and risk-modeling software to financial institutions and corporates. Alongside S&P Global, Moody's sits at the center of a durable ratings duopoly whose barriers to entry rest on regulatory recognition, decades of default data, and issuer-pays network effects, while Analytics provides a faster-growing, subscription-based counterweight that smooths the cyclicality of bond issuance volumes. The current investor debate centers on whether the ratings cycle has room to run after a strong 2026 issuance environment — Q3 revenue of $2.02 billion grew just 0.8% year over year against a tougher prior-year comparison, even as EPS rose to $4.25 from $3.61 — and on how quickly Moody's Analytics can scale AI-enabled decision tools before competitive pressure from S&P Global and data-platform entrants erodes pricing power. Sentiment has been further colored by the broader "AI disruption" narrative that has pressured information-services peers, with Moody's repeatedly framed in coverage as a wide-moat franchise trading at an attractive entry point after a soft patch.…
MCO
Moody's Corporation
$506.28
Related headlines
Investment Opinion: Should I buy MCO Today?
Rating: Hold with a constructive bias toward accumulating on weakness. The core thesis is that Moody's remains a wide-moat, duopoly-protected franchise whose elite margins (74.1% gross, 44.8% operating) and $2.977 billion TTM free cash flow justify a premium multiple, but with the stock at $508.20 against a $552.48 average analyst target implying only ~8.7% upside and Q3 revenue growth decelerating to 0.8% from 15.1% in Q2, the near-term risk/reward is balanced rather than compelling. The consensus "buy" rating (17 Buy, 7 Hold, 0 Sell, mean 1.75) anchors a positive directional view, but the modest implied return argues for patience rather than chasing at current levels.
The supporting evidence is genuinely strong on quality metrics. Forward PE of 27.3x represents a 27% compression from the 37.2x trailing multiple, and the 1.75 PEG prices growth at a broadly reasonable rate; gross margin expanded to 74.1% from 69.4% year over year, net margin rose to 36.3% from 32.2%, and Q3 EPS of $4.25 versus $3.61 a year earlier shows earnings compounding even as the top line stalls. Free cash flow of $2.977 billion (3.3% yield) comfortably funds $1.547 billion of Q2 buybacks, $388 million of Q3 buybacks, and $178 million of dividends, with interest coverage near 16.8x. Against a financial-data sector trading in the high-teens to low-20s PE, however, the 37.2x trailing and 11.9x sales multiples represent a 60–80% premium that requires continued margin delivery to defend.
The biggest risks that could invalidate the thesis are a sustained issuance slowdown compressing MIS revenue, AI-driven erosion of Analytics pricing power, and multiple compression toward the 22.5x historical trough. This Hold would upgrade to Buy if the stock pulls back toward the $480 analyst low target (roughly -5.5%) or if Q4 revenue growth reaccelerates above 5%, and would downgrade to Sell if revenue growth turns negative or gross margin falls back below 70%. On valuation, MCO is fairly valued to modestly rich relative to its own mid-band history and at a clear premium to peers — a quality premium that is defensible but leaves limited margin of safety at $508.20.
Sign up to view all
MCO 12-Month Price Forecast
Moody's presents a high-quality franchise at a fair-to-full price: elite margins, a regulated duopoly, and robust cash generation are offset by a near-flat Q3 top line and a 60–80% sector premium that leaves little room for error. The 27.3x forward PE and 1.75 PEG suggest the market has already priced the earnings-growth bridge, while the modest 8.7% average-target upside and wide $480–$600 dispersion argue for position-sizing discipline. The single most important variable is whether Q3's 0.8% revenue growth proves a seasonal trough or the start of a sustained slowdown — resolution of that question drives the entire thesis. I would upgrade to bullish on evidence of MIS issuance reacceleration or a pullback toward $480, and downgrade to bearish if revenue growth turns negative or gross margin slips below 70%.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Moody's Corporation's 12-month outlook, with a consensus price target around $553.67 and implied upside of +9.4% versus the current price.
Average Target
$553.67
24 analysts
Implied Upside
+9.4%
vs. current price
Analyst Count
24
covering this stock
Price Range
$480 - $600
Analyst target range
Coverage is broad and decidedly bullish: 21 analysts rate the stock, with 17 Buy, 7 Hold, and zero Sell, producing a consensus recommendation of "buy" and a mean rating of 1.75 on a 1-to-5 scale. The average target price of $552.48 implies roughly 8.7% upside from the current $508.20, a moderate rather than dramatic expected return that reflects how much of the recovery has already been captured by the recent rally. Consensus 2027 EPS of $26.97 (range $26.27–$27.47) and revenue of $10.51 billion (range $10.29–$10.66 billion) imply low-to-mid single-digit growth, consistent with the decelerating Q3 top line and suggesting the Street is underwriting margin resilience rather than a reacceleration in issuance. The target range of $480 to $600 is wide — a 25% spread from low to high — signaling genuine disagreement about the durability of the ratings cycle. The $600 high target, about 18% above the current price, would require multiple expansion toward the upper end of the historical PE band and/or a reacceleration in MIS volumes plus faster Analytics scaling; the $480 low target, roughly 5.5% below the current price, prices in margin compression and a fading issuance backdrop. Institutional actions are uniformly reiterations rather than upgrades or downgrades — Morgan Stanley at Equal Weight, Stifel and BofA at Buy, Wells Fargo and JPMorgan at Overweight, BMO at Market Perform, RBC at Outperform, Mizuho at Neutral — indicating stable conviction with a persistent bull/bear split between the ratings-cycle optimists and the valuation-conscious hold camp. The absence of any Sell ratings alongside a $480 floor that sits only modestly below the market price suggests downside is viewed as limited, but the modest average upside and wide dispersion argue for position sizing discipline rather than aggressive accumulation at current levels.
Bulls vs Bears: MCO Investment Factors
The bull case currently has the stronger evidence: expanding gross margins (74.1% vs. 69.4%), a 27% forward-PE compression to 27.3x, zero Sell ratings, and reasserting relative strength (+12.08 over one month) all point to a high-quality franchise trading at a reasonable-if-not-cheap entry point after a soft patch. The bear case rests on a genuine deceleration — Q3 revenue growth of just 0.8% versus 15.1% in Q2 — and a 60–80% sector premium that leaves little room for error. The single most important tension is whether the ratings cycle (MIS) can reaccelerate issuance volumes while Moody's Analytics scales AI-enabled tools fast enough to offset cyclicality; if Q3's near-flat top line proves a trough, the premium is justified, but if it marks the start of a sustained slowdown, multiple compression toward the 22.5x historical trough would be painful. With the average target implying only 8.7% upside and a wide $480–$600 dispersion, the risk/reward is balanced-to-positive rather than compelling at $508.20.
Bullish
- Elite margins expanding through cycle: Gross margin stepped up to 74.1% in Q3 2026 from 69.4% a year earlier, and the multi-quarter trajectory (66.9% Q4 2025 → 74.5% Q1 → 76.3% Q2 → 74.1% Q3) shows a durable step-up from the 2025 trough. Operating margin of 44.8% and net margin of 36.3% (up from 32.2%) demonstrate pricing power and operating leverage that few financial-data peers can match.
- Analyst consensus firmly bullish, no sells: 17 of 21 analysts rate MCO Buy with zero Sell ratings and a mean rating of 1.75, and the $552.48 average target implies 8.7% upside from $508.20. The $480 low target sits only ~5.5% below the current price, suggesting the Street views downside as structurally limited.
- Valuation compresses sharply on forward earnings: The stock trades at 37.2x trailing but only 27.3x forward earnings — a 27% compression — with a PEG of 1.75 that prices growth at a broadly reasonable rate. Consensus 2027 EPS of $26.97 versus the current run-rate supports that bridge, and at 37.2x PE the stock sits mid-band versus its own 22.5x–54.3x historical range.
- Momentum leadership reasserting: MCO has gained 9.82% over the past month while SPY fell 2.26%, a +12.08 relative-strength swing, and 6-month relative strength of +16.36 confirms outperformance since mid-year. The stock is up 18.49% over six months and sits at ~73% of its 52-week range, with a low 3.19 short ratio indicating no aggressive bear positioning.
Bearish
- Revenue growth has stalled to near-zero: Q3 2026 revenue of $2.023 billion grew just 0.8% year over year, a sharp deceleration from 15.1% in Q2 and 8.1% in Q1. Consensus 2027 revenue of $10.51 billion implies only low-to-mid single-digit growth, so the premium multiple is being underwritten on margins, not top-line reacceleration.
- Premium valuation versus sector: At 37.2x trailing PE, 11.9x sales, 22.6x book, and 24.5x EV/EBITDA, MCO trades at roughly a 60–80% premium to a financial-data sector that typically commands high-teens to low-20s PE. That premium is only defensible while margins hold and growth does not deteriorate further.
- Leverage and buyback-flattered returns: Debt-to-equity of 1.81x and cash of only $1.513 billion mean the company relies on recurring cash flow rather than balance-sheet liquidity. ROE of 60.7% is flattered by leverage and heavy buybacks ($1.547 billion in Q2 alone), so headline returns overstate underlying economic returns.
- Higher volatility and recent drawdown: Beta of 1.299 makes MCO roughly 30% more volatile than the market, and the 23.61% max drawdown over the trailing year shows the two-steps-forward, one-step-back pattern. The stock has lagged the S&P 500 by 8.72 points over one year despite a positive absolute return.
MCO Technical Analysis
Moody's is in a choppy but constructive uptrend that has recently reasserted itself. The stock is up 3.55% over the past year and 18.49% over six months, and at $508.20 it sits at roughly 73% of its 52-week range of $402.28 to $546.88 — comfortably above the midpoint but still about 7% below the high, a positioning that signals momentum without obvious overextension. The 23.61% maximum drawdown over the trailing year confirms this has been a two-steps-forward, one-step-back advance rather than a clean trend, and the 1-year relative strength of -8.72 versus the S&P 500 shows the stock has lagged the index despite its positive absolute return. Short-term momentum has turned decisively positive and is diverging bullishly from the muted 1-year record. The stock has gained 9.82% over the past month and 4.79% over three months, with the 1-month relative strength of +12.08 versus SPY (which fell 2.26% over the same span) marking a sharp acceleration in leadership; the 6-month relative strength of +16.36 reinforces that the stock has been outperforming since mid-year. The path was not linear — a September slide from the $514.95 late-August high down to $441.36 on October 2 gave way to a powerful October–November rally, including a 4.9% single-day jump to $528.34 on November 4 — and the 3.19 short ratio suggests short sellers are not aggressively positioned against the name. Key levels are well defined: resistance sits at the $546.88 52-week high, roughly 7.6% above the current price, and a breakout there would confirm a fresh leg higher and likely draw momentum buyers; support rests at the $402.28 52-week low, about 21% below, with intermediate support in the $440–$460 zone where the October basing occurred. With a beta of 1.299, Moody's is roughly 30% more volatile than the market, meaning position sizing should account for amplified drawdowns — the 23.61% max drawdown is a realistic stress-case guide — and the current price of $508.20 sits just 0.32% above the prior close, indicating a pause after the early-November surge.
Beta
1.30
1.30x market volatility
Max Drawdown
-23.6%
Largest decline past year
52-Week Range
$402-$547
Price range past year
Annual Return
+5.6%
Cumulative gain past year
| Period | MCO Return | S&P 500 |
|---|---|---|
| 1m | +4.4% | -3.0% |
| 3m | +4.2% | -3.6% |
| 6m | +14.0% | -0.2% |
| 1y | +5.6% | +10.1% |
| ytd | +1.5% | +8.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
MCO Fundamental Analysis
Revenue growth has decelerated sharply even as absolute levels remain healthy. Q3 2026 revenue of $2.023 billion grew only 0.8% year over year versus $2.007 billion in Q3 2025, a marked slowdown from the prior quarters: Q2 2026 revenue of $2.185 billion rose 15.1% over Q2 2025's $1.898 billion, and Q1 2026's $2.079 billion grew 8.1% over $1.924 billion. The sequential pattern — $2.079 billion, $2.185 billion, $2.023 billion — shows Q3 as the seasonal soft spot, but the near-flat YoY print is a genuine deceleration that puts pressure on the ratings-cycle thesis. Segment data for the period shows Moody's Analytics at $1.301 billion and MIS at $722 million, an unusual mix that implies Analytics carried roughly 64% of revenue in the reported period, underscoring the strategic importance of the subscription business in offsetting issuance volatility. Profitability remains elite and is trending favorably. Q3 2026 net income of $734 million on a 36.3% net margin compares with $646 million and a 32.2% margin in Q3 2025, while gross margin expanded to 74.1% from 69.4% a year earlier and operating margin reached 44.8% versus 45.7%. The multi-quarter gross margin trajectory — 66.9% in Q4 2025, 74.5% in Q1 2026, 76.3% in Q2 2026, 74.1% in Q3 2026 — shows a clear step-up from the 2025 trough, and EBITDA of $914 million (45.2% margin) remains robust even as it dipped from $1.03 billion in Q1. These margins are exceptional for financial services and reflect the pricing power of the ratings franchise plus operating leverage in Analytics. The balance sheet is leveraged but comfortably serviced, with cash generation funding aggressive capital returns. Debt-to-equity stands at 1.81x with a current ratio of 1.74, and TTM free cash flow of $2.977 billion against a $91.5 billion market cap implies an FCF yield of roughly 3.3%; Q3 operating cash flow of $753 million less $85 million of capex produced $668 million of FCF. ROE of 60.7% and ROA of 15.6% are exceptional, though flattered by leverage and buybacks — the company repurchased $388 million of stock in Q3 and $1.547 billion in Q2, alongside $178 million of dividends, and interest coverage of roughly 16.8x leaves ample cushion. Cash of $1.513 billion at quarter-end is adequate rather than abundant, meaning the company relies on its recurring cash flow engine rather than balance-sheet liquidity to fund returns.
Quarterly Revenue
$2.0B
2026-09
Revenue YoY Growth
+0.8%
YoY Comparison
Gross Margin
74.1%
Latest Quarter
Free Cash Flow
$3.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is MCO Overvalued?
Because Moody's is solidly profitable — Q3 net income of $734 million and a 31.9% net margin — the PE ratio is the appropriate primary metric. The stock trades at 37.2x trailing earnings but only 27.3x forward earnings, a 27% compression that implies the market expects meaningful EPS growth; consensus 2027 EPS of $26.97 against the current run-rate supports that bridge, and the 1.75 PEG ratio suggests the growth is being paid for at a broadly reasonable, if not cheap, rate. On the secondary metrics the picture is richer: 11.9x sales, 22.6x book, 31.5x cash flow, and 24.5x EV/EBITDA, all consistent with a high-margin, asset-light franchise. Against the financial data and stock exchange industry, Moody's commands a clear premium — a 37.2x trailing PE versus a sector that typically trades in the high-teens to low-20s, and 11.9x sales versus low-single-digit norms for diversified financials — a spread of roughly 60–80% depending on the metric. That premium is defensible on quality grounds: 68.2% gross margins, 44.8% operating margins, 60.7% ROE, and a regulated duopoly position are not characteristics the average financial-data peer possesses, though the near-flat Q3 revenue growth of 0.8% is the key risk to premium persistence. Historically, Moody's own valuation band has been wide: trailing PE ranged from about 22.5x in Q2 2026 to 54.3x in Q4 2024, and PS ranged from roughly 34.9x to 51.5x over the same period. At 37.2x PE the stock sits in the middle-to-upper portion of that band — above the 22.5x trough but well below the 54.3x peak — while the 11.9x PS is distorted by the market-cap source difference and is best read against the historical 35–51x series as a relative, not absolute, signal. The takeaway is that valuation is neither a screaming bargain nor stretched to prior extremes, leaving earnings delivery as the swing factor.
PE
37.2x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 23x~54x
vs. Industry Avg
32.4x
Industry PE ~32.4x*
EV/EBITDA
24.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on the abrupt revenue deceleration and the leverage that flatters returns. Q3 2026 revenue grew only 0.8% year over year versus 15.1% in Q2, and consensus 2027 revenue of $10.51 billion implies low-to-mid single-digit growth — meaning the 37.2x trailing PE depends on margin resilience rather than top-line momentum. Debt-to-equity of 1.81x with only $1.513 billion of cash means capital returns ($1.547 billion of buybacks in Q2, $388 million in Q3, plus $178 million of dividends) are funded by the $2.977 billion TTM free cash flow engine; any issuance downturn that compresses MIS cash flow would force a choice between buybacks and deleveraging. ROE of 60.7% is flattered by leverage and buybacks, so underlying economic returns are lower than the headline suggests.
Market and competitive risks are dominated by valuation compression and the AI-disruption narrative. At 37.2x trailing PE, 11.9x sales, and 24.5x EV/EBITDA, MCO trades at a 60–80% premium to a financial-data sector in the high-teens to low-20s PE, a spread that requires continued margin delivery to defend. Recent coverage has framed S&P Global's ~25% decline as driven by overblown AI disruption fears, and if AI-enabled data tools genuinely erode pricing power in Moody's Analytics (64% of reported revenue at $1.301 billion), the premium would compress. Beta of 1.299 amplifies market sensitivity, and the stock has already lagged the S&P 500 by 8.72 points over one year despite a positive absolute return, showing sector rotation risk is real.
The worst-case scenario is a synchronized hit: a fading bond-issuance backdrop compresses MIS revenue, AI-driven competition pressures Analytics pricing, and the premium multiple mean-reverts toward the 22.5x historical trough. From $508.20, a move to the $402.28 52-week low would represent roughly -21%, and the 23.61% trailing max drawdown is a realistic stress guide for a beta-1.299 name. The analyst low target of $480 (-5.5%) prices in margin compression and a fading issuance backdrop but not a full de-rating; a genuine cycle turn plus multiple compression could plausibly take the stock toward the low-$400s, a -20% to -25% downside from current levels.
FAQ
Ranked by severity, the first risk is revenue deceleration: Q3 2026 revenue grew only 0.8% year over year versus 15.1% in Q2, and consensus 2027 revenue of $10.51 billion implies only low-to-mid single-digit growth, so the 37.2x trailing multiple depends on margins rather than top-line momentum. Second is valuation compression: at 11.9x sales and 24.5x EV/EBITDA, MCO carries a 60–80% premium to financial-data peers, and a mean-reversion toward the 22.5x historical PE trough would be painful given the $402.28 52-week low sits ~21% below the current price. Third is competitive/AI disruption: Moody's Analytics at $1.301 billion (roughly 64% of reported revenue in the period) faces pricing pressure from S&P Global and data-platform entrants, a theme that has already contributed to S&P Global's ~25% drawdown on AI fears. Fourth is financial leverage and market sensitivity: debt-to-equity of 1.81x with only $1.513 billion of cash means buybacks ($1.547 billion in Q2, $388 million in Q3) depend on the $2.977 billion FCF engine, and a beta of 1.299 amplifies drawdowns — the stock has already lagged the S&P 500 by 8.72 points over one year.
The 12-month forecast splits into a 55% base case of $530–$560 (anchored on the $552.48 average analyst target), a 25% bull case of $575–$600 (the $600 high target, requiring MIS issuance reacceleration and multiple expansion), and a 20% bear case of $440–$480 (the $480 low target down toward the October basing zone). The base case is most likely and assumes 2027 revenue near the $10.51 billion consensus, gross margin holding above 70%, operating margin near 44%, and continued $1 billion-plus annual buybacks supporting EPS toward $26.97 — with no multiple re-rating. The bull case needs Q4 2026 MIS issuance volumes to reaccelerate into double digits and 2027 EPS guidance above the $27.47 high end, while the bear case assumes fading issuance plus AI-driven Analytics pricing pressure and multiple compression toward 22.5x. The wide $480–$600 dispersion (a 25% spread) reflects genuine analyst disagreement about the durability of the ratings cycle, so treat the point estimate with appropriate humility.
MCO is fairly valued to modestly rich on its own history and clearly at a premium to peers. The stock trades at 37.2x trailing earnings but only 27.3x forward earnings, with a 1.75 PEG that prices growth at a broadly reasonable rate; on secondary metrics it is richer at 11.9x sales, 22.6x book, 31.5x cash flow, and 24.5x EV/EBITDA. Against a financial-data sector that typically trades in the high-teens to low-20s PE, that is roughly a 60–80% premium, defensible only because of 68.2% gross margins, 44.8% operating margins, 60.7% ROE, and a regulated duopoly. Within its own band, trailing PE has ranged from about 22.5x in Q2 2026 to 54.3x in Q4 2024, so at 37.2x the stock sits in the middle-to-upper portion — above the trough but well below the peak. The valuation implies the market expects the forward EPS bridge toward the $26.97 2027 consensus to be delivered; if revenue growth stays near 0.8%, the multiple has room to compress toward the low end of that band.
From a risk/reward standpoint MCO is a reasonable but not compelling buy at $508.20: the average analyst target of $552.48 implies about 8.7% upside, while the $480 low target sits only ~5.5% below the current price, so the near-term skew is modestly favorable rather than asymmetric. The quality case is strong — 74.1% gross margin, 44.8% operating margin, $2.977 billion of TTM free cash flow, and a 27.3x forward PE that is 27% below the 37.2x trailing multiple — and 17 of 21 analysts rate it Buy with zero Sells. The biggest downside risk is that Q3 revenue growth of just 0.8% (versus 15.1% in Q2) marks the start of an issuance slowdown, which would expose the 60–80% sector premium and could take the stock toward the $402.28 52-week low, roughly -21%. It is therefore a good buy primarily for long-horizon investors comfortable with a beta of 1.299 and a 23.61% trailing max drawdown, and best accumulated on pullbacks toward $480 or on evidence of MIS issuance reacceleration rather than chased after the 9.82% one-month rally.
MCO is better suited to long-term holding than short-term trading. The franchise characteristics — a regulated ratings duopoly, 74.1% gross margins, 60.7% ROE, and $2.977 billion of TTM free cash flow — compound over multi-year periods, and the earnings bridge from 37.2x trailing to 27.3x forward PE means returns should come from EPS growth plus modest multiple support rather than quick re-rating. Short-term traders face a beta of 1.299, a 23.61% trailing max drawdown, and a choppy pattern (a September slide from $514.95 to $441.36 on October 2, then a 4.9% single-day jump to $528.34 on November 4), which demands tight risk controls around the $546.88 resistance and $440–$460 support. The 0.77% dividend yield with a 28.5% payout provides little income cushion, so this is not an income vehicle. A suggested minimum holding period is three to five years, with position sizing that accounts for 20%+ drawdowns and accumulation prioritized on pullbacks toward $480 or on confirmation that Q4 revenue growth has reaccelerated above 5%.

